Prenatal Metformin Exposure in Mice Programs the Metabolic Phenotype of the Offspring during a High Fat Diet at Adulthood
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
AIMS: The antidiabetic drug metformin is currently used prior and during pregnancy for polycystic ovary syndrome, as well as during gestational diabetes mellitus. We investigated the effects of prenatal metformin exposure on the metabolic phenotype of the offspring during adulthood in mice. METHODS: Metformin (300 mg/kg) or vehicle was administered orally to dams on regular diet from the embryonic day E0.5 to E17.5. Gene expression profiles in liver and brain were analysed from 4-day old offspring by microarray. Body weight development and several metabolic parameters of offspring were monitored both during regular diet (RD-phase) and high fat diet (HFD-phase). At the end of the study, two doses of metformin or vehicle were given acutely to mice at the age of 20 weeks, and Insig-1 and GLUT4 mRNA expressions in liver and fat tissue were analysed using qRT-PCR. RESULTS: Metformin exposed fetuses were lighter at E18.5. There was no effect of metformin on the maternal body weight development or food intake. Metformin exposed offspring gained more body weight and mesenteric fat during the HFD-phase. The male offspring also had impaired glucose tolerance and elevated fasting glucose during the HFD-phase. Moreover, the expression of GLUT4 mRNA was down-regulated in epididymal fat in male offspring prenatally exposed to metformin. Based on the microarray and subsequent qRT-PCR analyses, the expression of Insig-1 was changed in the liver of neonatal mice exposed to metformin prenatally. Furthermore, metformin up-regulated the expression of Insig-1 later in development. Gene set enrichment analysis based on preliminary microarray data identified several differentially enriched pathways both in control and metformin exposed mice. CONCLUSIONS: The present study shows that prenatal metformin exposure causes long-term programming effects on the metabolic phenotype during high fat diet in mice. This should be taken into consideration when using metformin as a therapeutic agent during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The metformin-exposed mice gained more weight postnatally, and the male offspring, when they were fed a HFD, became more adipose and more of them developed glucose intolerance than placebo-exposed offspring.17”
From Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age (2018) · cites this paper as [17]
In the citing paper
“In a mouse model, in which pregnant dams were lean and fed with their usual chow, metformin treatment was associated with the offspring being lighter at birth, with a similar phenotype to offspring exposed to undernutrition in utero.17”
From Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age (2018) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524 · cited 1×
“In order to calculate the human dose, an allometric body surface area method (BSA) [35] was used.”
MethodRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 6×
“AMPK is a cellular energy regulator that activates ATP-producing metabolic pathways [5,6] and autophagy [7,8] to normalise the energy balance of the cells.”
BackgroundInfluentialKEGG for integration and interpretation of large-scale molecular data sets
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr988 · Cited by 4,848
The fetal and infant origins of adult disease.
Barker, D. J. (1990) · BMJ · doi:10.1136/bmj.301.6761.1111 · Cited by 2,768
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488 · cited 1×
“PCOS affects approximately 10% of women of reproductive age and the main features include hyperandrogenemia, hirsutism, oligoanovulation and polycystic ovaries [59].”
BackgroundAdipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O., Kim, J. K., Kim, Y.-B., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,253
Trophic Action of Leptin on Hypothalamic Neurons That Regulate Feeding
Bouret, S. G., Draper, S. J., & Simerly, R. B. (2004) · Science · doi:10.1126/science.1095004 · Cited by 1,218
Carone, B. R., Fauquier, L., Habib, N., Shea, J. M., Hart, C. E., Li, R., Bock, C., Li, C., Gu, H., Zamore, P. D., et al. (2010) · Cell · doi:10.1016/j.cell.2010.12.008 · Cited by 1,159
AMP-activated protein kinase signaling in metabolic regulation
Long, Y. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29044 · Cited by 1,098
Mechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052
Vickers, M. H., Breier, B. H., Cutfield, W. S., Hofman, P. L., & Gluckman, P. D. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.1.e83 · Cited by 999 · cited 1×
“Metformin exposed offspring had a phenotype which resembled that of offspring from maternal undernourishment models [37,38].”
BackgroundCrucial Step in Cholesterol Homeostasis
Yang, T., Espenshade, P. J., Wright, M. E., Yabe, D., Gong, Y., Aebersold, R., Goldstein, J. L., & Brown, M. S. (2002) · Cell · doi:10.1016/s0092-8674(02)00872-3 · Cited by 987
Reactome knowledgebase of human biological pathways and processes
Matthews, L., Gopinath, G., Gillespie, M., Caudy, M., Croft, D., de Bono, B., Garapati, P., Hemish, J., Hermjakob, H., Jassal, B., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn863 · Cited by 873 · cited 1×
“Gene set databases BIOCARTA [25], KEGG [26,27] and REACTOME [28] were used (downloaded from Board Institute at MIT).”
MethodHawley, S. A., Gadalla, A. E., Olsen, G. S., & Hardie, D. G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2420 · Cited by 696
Onken, B., & Driscoll, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008758 · Cited by 671
Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health
Meaney, M. J., Szyf, M., & Seckl, J. R. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.05.003 · Cited by 668
Epigenetic mechanisms that underpin metabolic and cardiovascular diseases
Gluckman, P. D., Hanson, M. A., Buklijas, T., Low, F. M., & Beedle, A. S. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.102 · Cited by 627
Neonatal Leptin Treatment Reverses Developmental Programming
Vickers, M. H., Gluckman, P. D., Coveny, A. H., Hofman, P. L., Cutfield, W. S., Gertler, A., Breier, B. H., & Harris, M. (2005) · Endocrinology · doi:10.1210/en.2005-0581 · Cited by 617
Nishimura, D. (2001) · Biotech Software & Internet Report · doi:10.1089/152791601750294344 · Cited by 567
Shang, L., Chen, S., Du, F., Li, S., Zhao, L., & Wang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100844108 · Cited by 517
Effects of Metformin on Early Pregnancy Loss in the Polycystic Ovary Syndrome
Jakubowicz, D. J., Iuorno, M. J., Jakubowicz, S., Roberts, K. A., & Nestler, J. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8207 · Cited by 492
Xie, Z., Lau, K., Eby, B., Lozano, P., He, C., Pennington, B., Li, H., Rathi, S., Dong, Y., Tian, R., et al. (2011) · Diabetes · doi:10.2337/db10-0351 · Cited by 490 · cited 1×
“The dose (300 mg/kg) for metformin administration was selected based on previously published studies of the effects of metformin in rodents [31–34].”
MethodRole of premature leptin surge in obesity resulting from intrauterine undernutrition
Yura, S., Itoh, H., Sagawa, N., Yamamoto, H., Masuzaki, H., Nakao, K., Kawamura, M., Takemura, M., Kakui, K., Ogawa, Y., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.005 · Cited by 387
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
Rowan, J. A., Rush, E. C., Obolonkin, V., Battin, M., Wouldes, T., & Hague, W. M. (2011) · Diabetes Care · doi:10.2337/dc11-0660 · Cited by 379
Nutritional programming of the metabolic syndrome
Symonds, M. E., Sebert, S. P., Hyatt, M. A., & Budge, H. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.195 · Cited by 368
Kabir, M., Catalano, K. J., Ananthnarayan, S., Kim, S. P., Van Citters, G. W., Dea, M. K., & Bergman, R. N. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00203.2004 · Cited by 327
Sandovici, I., Smith, N. H., Nitert, M. D., Ackers-Johnson, M., Uribe-Lewis, S., Ito, Y., Jones, R. H., Marquez, V. E., Cairns, W., Tadayyon, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019007108 · Cited by 326
Metformin: New Understandings, New Uses
Hundal, R. S., & Inzucchi, S. E. (2003) · Drugs · doi:10.2165/00003495-200363180-00001 · Cited by 308
Maida, A., Lamont, B. J., Cao, X., & Drucker, D. J. (2011) · Diabetologia · doi:10.1007/s00125-010-1937-z · Cited by 294
Sexual dimorphism in environmental epigenetic programming
Gabory, A., Attig, L., & Junien, C. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.015 · Cited by 279
Glueck, C. J. (2004) · Human Reproduction · doi:10.1093/humrep/deh263 · Cited by 250
Velazquez, E. M., Mendoza, S. G., Wang, P., & Glueck, C. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90066-4 · Cited by 249
Placental passage of metformin in women with polycystic ovary syndrome
Vanky, E., Zahlsen, K., Spigset, O., & Carlsen, S. M. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.051 · Cited by 245
Morin-Papunen, L., Rantala, A. S., Unkila-Kallio, L., Tiitinen, A., Hippeläinen, M., Perheentupa, A., Tinkanen, H., Bloigu, R., Puukka, K., Ruokonen, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3061 · Cited by 243
Nestler, J. E., Stovall, D., Akhter, N., Iuorno, M. J., & Jakubowicz, D. J. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02963-6 · Cited by 230
Raychaudhuri, N., Raychaudhuri, S., Thamotharan, M., & Devaskar, S. U. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800128200 · Cited by 227
Levin, B. E. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1851 · Cited by 221
Ijäs, H., Vääräsmäki, M., Morin-Papunen, L., Keravuo, R., Ebeling, T., Saarela, T., & Raudaskoski, T. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02763.x · Cited by 215
Epigenetic mechanisms in the development of type 2 diabetes
Pinney, S. E., & Simmons, R. A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.10.002 · Cited by 205 · cited 1×
“Previous studies have shown that intrauterine growth restriction can down-regulate the expression of GLUT4 by epigenetic mechanisms in the muscle of rats [56] and this potentially contributes to the development of metabolic disturbances in later development [57].”
BackgroundReproductive and Metabolic Phenotype of a Mouse Model of PCOS
van Houten, E. L. A. F., Kramer, P., McLuskey, A., Karels, B., Themmen, A. P. N., & Visser, J. A. (2012) · Endocrinology · doi:10.1210/en.2011-1754 · Cited by 184
Vickers, M. H., Gluckman, P. D., Coveny, A. H., Hofman, P. L., Cutfield, W. S., Gertler, A., Breier, B. H., & Harris, M. A. (2008) · Endocrinology · doi:10.1210/en.2007-0981 · Cited by 175
Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
Bhalla, K., Hwang, B. J., Dewi, R. E., Twaddel, W., Goloubeva, O. G., Wong, K., Saxena, N. K., Biswal, S. S., & Girnun, G. D. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0228 · Cited by 162
Roth, A. B., Looser, R., Kaufmann, M., Blättler, S. M., Rencurel, F., Huang, W., Moore, D. D., & Meyer, U. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.041012 · Cited by 161
Insig-1 “brakes” lipogenesis in adipocytes and inhibits differentiation of preadipocytes
Li, J., Takaishi, K., Cook, W., McCorkle, S. K., & Unger, R. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133426100 · Cited by 124
Attig, L., Solomon, G., Férézou, J., Abdennebi‐Najar, L., Taouis, M., Gertler, A., & Djiane, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.39 · Cited by 122
Identification of potential caloric restriction mimetics by microarray profiling
Dhahbi, J. M., Mote, P. L., Fahy, G. M., & Spindler, S. R. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00069.2005 · Cited by 122
Sinnett‐Smith, J. W., Kisfalvi, K., Kui, R. K., & Rozengurt, E. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.010 · Cited by 119
Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome
Glueck, C. J., Bornovali, S., Pranikoff, J., Goldenberg, N., Dharashivkar, S., & Wang, P. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01251.x · Cited by 115
Tertti, K., Ekblad, U., Vahlberg, T. J., & Rönnemaa, T. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.95 · Cited by 111
Caton, P. W., Kieswich, J., Yaqoob, M. M., Holness, M. J., & Sugden, M. C. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01466.x · Cited by 101
Metformin for gestational diabetes in routine clinical practice
Goh, J. E. L., Sadler, L., & Rowan, J. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03361.x · Cited by 99
Should we continue or stop insulin sensitizing drugs during pregnancy?
Norman, R. J., Wang, J. X., & Hague, W. M. (2004) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200406000-00007 · Cited by 75
Protective effect of metformin in CD1 mice placed on a high carbohydrate–high fat diet
Hou, M., Venier, N. A., Sugar, L., Musquera, M., Pollak, M., Kiss, A., Fleshner, N. E., Klotz, L. H., & Venkateswaran, V. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.152 · Cited by 48
Zakikhani, M., Bazile, M., Hashemi, S., Javeshghani, S., Avizonis, D. Z., St‐Pierre, J., & Pollak, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049513 · Cited by 40
Neonatal Exposure to Leptin Augments Diet‐induced Obesity in Leptin‐deficient Ob/Ob Mice
Yura, S., Itoh, H., Sagawa, N., Yamamoto, H., Masuzaki, H., Nakao, K., Kawamura, M., Mogami, H., Ogawa, Y., & Fujii, S. (2008) · Obesity · doi:10.1038/oby.2008.57 · Cited by 34
Metformin during Pregnancy in Polycystic Ovary Syndrome: Another Vitamin Bites the Dust
Legro, R. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2301 · Cited by 15
Neonatal exposure to leptin reduces glucose tolerance in adult mice
Itoh, H., Yura, S., Sagawa, N., Kanayama, N., Konihi, I., & Hamamatsu Birth Cohort for Mothers and Children (HBC) Study Team (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02268.x · Cited by 13
Cited by
Rowan, J. A., Rush, E. C., Plank, L. D., Lu, J., Obolonkin, V., Coat, S., & Hague, W. M. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000456 · Cited by 305
Hanem, L. G. E., Stridsklev, S., Júlíusson, P. B., Salvesen, Ø., Roelants, M., Carlsen, S. M., Ødegård, R., & Vanky, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02419 · Cited by 199
Hanem, L. G. E., Salvesen, Ø., Juliusson, P. B., Carlsen, S. M., Nossum, M. C. F., Vaage, M. Ø., Ødegård, R., & Vanky, E. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30385-7 · Cited by 134
Ijäs, H., Vääräsmäki, M., Saarela, T., Keravuo, R., & Raudaskoski, T. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12964 · Cited by 139
Izzo, A., Nitti, M. P., Mollo, N., Paladino, S., Procaccini, C., Faicchia, D., Calì, G., Genesio, R., Bonfiglio, F., Cicatiello, R., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx016 · Cited by 112
Metadata
- Authors
- Salomäki, H., Vähätalo, L. H., Laurila, K., Jäppinen, N. T., Penttinen, A.-M., Ailanen, L., Ilyasizadeh, J., Pesonen, U., & Koulu, M.
- Affiliations
- University of Turku (FI)
- Aalto University (FI)
- Corresponding author
- Koulu, Markku
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-02-15
- Volume
- 8
- Issue
- 2
- Pages
- e56594
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3574083
- OpenAlex
- W2063226778
- Cited by
- 92
- References
- 64
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 5 · 2023: 11 · 2022: 3 · 2021: 16 · 2020: 6 · 2019: 6 · 2018: 19 · 2017: 5 · 2016: 4 · 2015: 1 · 2014: 7 · 2013: 2
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-10-16)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Aaltodoc (Aalto University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Kela
- Academy of Finland (134131)
- Turun Yliopisto
- Turun Yliopistollinen Keskussairaala
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, prenatal drug exposure, developmental programming, high-fat diet, glucose tolerance, GLUT4, INSIG1, hepatic gene expression, adipose tissue, weight gain, polycystic ovary syndrome, gestational diabetes mellitus
- MeSH terms
- Animals, Body Weight, Eating, Female, Fetus, Gene Expression Regulation, Glucose Tolerance Test, Hypoglycemic Agents, Liver, Male, Membrane Proteins, Metformin, Mice, Inbred C57BL, Organ Size, Phenotype, Pregnancy, Prenatal Exposure Delayed Effects, Maternal Exposure, Glucose Transporter Type 4, Mice, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.